The endothelial barrier and cancer metastasis: Does the protective facet of platelet function matter?
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 176, 113886
Abstract
No abstract availableKeywords
Funding Information
- National Centre for Research and Development
This publication has 118 references indexed in Scilit:
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Epidemiology and pathophysiology of cancer-associated thrombosisBritish Journal of Cancer, 2010
- ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFαMicrovascular Research, 2010
- Concentration dependent dual effect of thrombin in endothelial cells via Par‐1 and Pi3 KinaseJournal of Cellular Physiology, 2009
- Platelets, Petechiae, and Preservation of the Vascular WallNew England Journal of Medicine, 2008
- Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trialBritish Journal of Cancer, 2008
- PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor ActivationJournal of Biological Chemistry, 2006
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences, 1968